Dermata Therapeutics, Inc. (DRMAW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.15M |
| Enterprise Value | -5.37M |
| P/E Ratio | -0.23 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.73 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.86 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.95 |
| Return On Equity | -1.28 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -7.56M |
| Net Income | -7.56M |
| Diluted EPS | -8.16 |
| Total Cash | 6.95M |
| Total Cash/Share | 1.8 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.09 |
| Book Value Per Share | 1.66 |
| 52-Week Change | -38.54 |
| 52-Week High | 0.02 |
| 52-Week Low | 0.01 |
| Moving Average 50 Days | 0.02 |
| Moving Average 200 Days | 0.02 |
| Average Volume | 7,130.77 |
| Shares Outstanding | 681,557 |
| % Held by Institutions | 1.44 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |